These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23451025

  • 21. Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.
    Krämer J, Lueg G, Schiffler P, Vrachimis A, Weckesser M, Wenning C, Pawlowski M, Johnen A, Teuber A, Wersching H, Meuth SG, Duning T.
    J Alzheimers Dis; 2018; 63(1):239-253. PubMed ID: 29614640
    [Abstract] [Full Text] [Related]

  • 22. Correlations between clinical characteristics and neuroimaging in Chinese patients with subtypes of frontotemporal lobe degeneration.
    Shi Z, Liu S, Wang Y, Liu S, Han T, Cai L, Zhou Y, Gao S, Ji Y.
    Medicine (Baltimore); 2017 Sep; 96(37):e7948. PubMed ID: 28906375
    [Abstract] [Full Text] [Related]

  • 23. Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.
    Buhour MS, Doidy F, Laisney M, Pitel AL, de La Sayette V, Viader F, Eustache F, Desgranges B.
    Brain Imaging Behav; 2017 Feb; 11(1):240-252. PubMed ID: 26852326
    [Abstract] [Full Text] [Related]

  • 24. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.
    Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M, EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [Abstract] [Full Text] [Related]

  • 25. Clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis.
    Perini G, Rodriguez-Vieitez E, Kadir A, Sala A, Savitcheva I, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):612-622. PubMed ID: 32734458
    [Abstract] [Full Text] [Related]

  • 26. Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - a pilot FDG-PET study.
    Raczka KA, Becker G, Seese A, Frisch S, Heiner S, Marschhauser A, Barthel H, Scheid R, Sabri O, Schroeter ML.
    Psychiatry Res; 2010 Jun 30; 182(3):274-80. PubMed ID: 20493673
    [Abstract] [Full Text] [Related]

  • 27. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG, Wenzel F, Gartenschläger M, Thiele F, Young S, Reuss S, Schreckenberger M.
    Biomed Eng Online; 2015 Aug 18; 14():79. PubMed ID: 26281849
    [Abstract] [Full Text] [Related]

  • 28. Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations.
    Licata A, Grimmer T, Winkelmann J, Wagner M, Goldhardt O, Riedl L, Roßmeier C, Yakushev I, Diehl-Schmid J.
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug 18; 21(5-6):389-395. PubMed ID: 32567375
    [Abstract] [Full Text] [Related]

  • 29. Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia.
    Oh JS, Oh M, Chung SJ, Kim JS.
    Neuroreport; 2014 Oct 22; 25(15):1198-202. PubMed ID: 25144395
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D, Iida K, Higaki T, Kaichi Y, Takauchi K, Arihiro K, Kakita A, Hirokawa Y, Awai K.
    Hiroshima J Med Sci; 2015 Dec 22; 64(4):51-7. PubMed ID: 26964154
    [Abstract] [Full Text] [Related]

  • 31. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
    Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappatà S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L, EADC-PET Consortium.
    Neuroimage Clin; 2014 Dec 22; 6():445-54. PubMed ID: 25389519
    [Abstract] [Full Text] [Related]

  • 32. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
    Goossens J, Bjerke M, Van Mossevelde S, Van den Bossche T, Goeman J, De Vil B, Sieben A, Martin JJ, Cras P, De Deyn PP, Van Broeckhoven C, van der Zee J, Engelborghs S.
    Alzheimers Res Ther; 2018 Mar 20; 10(1):31. PubMed ID: 29559004
    [Abstract] [Full Text] [Related]

  • 33. A computed tomography-based spatial normalization for the analysis of [18F] fluorodeoxyglucose positron emission tomography of the brain.
    Cho H, Kim JS, Choi JY, Ryu YH, Lyoo CH.
    Korean J Radiol; 2014 Mar 20; 15(6):862-70. PubMed ID: 25469101
    [Abstract] [Full Text] [Related]

  • 34. Reducing instability of inter-subject covariance of FDG uptake networks using structure-weighted sparse estimation approach.
    Wang M, Schutte M, Grimmer T, Lizarraga A, Schultz T, Hedderich DM, Diehl-Schmid J, Rominger A, Ziegler S, Navab N, Yan Z, Jiang J, Yakushev I, Shi K.
    Eur J Nucl Med Mol Imaging; 2022 Dec 20; 50(1):80-89. PubMed ID: 36018359
    [Abstract] [Full Text] [Related]

  • 35. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study.
    Borroni B, Agosti C, Premi E, Cerini C, Cosseddu M, Paghera B, Bellelli G, Padovani A.
    Eur J Neurol; 2010 May 20; 17(5):703-7. PubMed ID: 20050899
    [Abstract] [Full Text] [Related]

  • 36. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J.
    Dement Geriatr Cogn Disord; 2010 May 20; 29(5):448-56. PubMed ID: 20502019
    [Abstract] [Full Text] [Related]

  • 37. Removing outliers from the normative database improves regional atrophy detection in single-subject voxel-based morphometry.
    Schultz V, Hedderich DM, Schmitz-Koep B, Schinz D, Zimmer C, Yakushev I, Apostolova I, Özden C, Opfer R, Buchert R.
    Neuroradiology; 2024 Apr 20; 66(4):507-519. PubMed ID: 38378906
    [Abstract] [Full Text] [Related]

  • 38. Cerebrospinal Fluid Amyloid-β Subtypes in Confirmed Frontotemporal Lobar Degeneration Cases: A Pilot Study.
    Verwey NA, Teunissen CE, Hoozemans JJM, Rozemuller AJM, Scheltens P, Pijnenburg YAL.
    J Alzheimers Dis; 2019 Apr 20; 71(1):15-20. PubMed ID: 31356209
    [Abstract] [Full Text] [Related]

  • 39. [Brain functional imaging of frontotemporal lobar degeneration].
    Nakano S, Matsuda H.
    Brain Nerve; 2009 Nov 20; 61(11):1275-84. PubMed ID: 19938684
    [Abstract] [Full Text] [Related]

  • 40. Making the diagnosis of frontotemporal lobar degeneration.
    Bigio EH.
    Arch Pathol Lab Med; 2013 Mar 20; 137(3):314-25. PubMed ID: 23451743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.